BEIJING - After a 10-month investigation, China’s Ministry of Public Security (MPS) has formally charged that GlaxoSmithKline PLC ex-China head Mark Reilly and two Chinese executives offered bribes to boost pharmaceutical sales in China.
Reilly incorporated money used to pay bribes into the cost of drug sales since January 2009 when he became general...